|
1 |
17 04 2026 |
PLI schemes, digital adoption, etc to transition India from generic powerhouse to innovation-driven hub: Experts |
Pharmabiz |
India |
|
2 |
17 04 2026 |
Share of pharma in merchandise exports grew to almost 7 per cent in 2024-25 |
Pharmabiz |
India |
|
3 |
17 04 2026 |
Operational realities & global strategy realignment force MNCs to scale back their units in India: Dr Shenoy |
Pharmabiz |
India |
|
4 |
17 04 2026 |
MDC seeks written reply from Biological E on exemption of Pneubevax 14 from DPCO pricing |
Pharmabiz |
India |
|
5 |
17 04 2026 |
Pharma traders fume over restrictive labelling norms in new medical device draft rules |
Pharmabiz |
India |
|
6 |
17 04 2026 |
DCGI pushes reforms drug approvals now within 150 days |
Medical Dialogues |
India |
|
7 |
17 04 2026 |
Hetero Targets 1.5 million Semaglutide Pens eyes 75+ markets |
Medical Dialogues |
India |
|
8 |
17 04 2026 |
USFDA to review Peptide compounding ban advisory panel meet set for July |
Medical Dialogues |
India |
|
9 |
17 04 2026 |
US, Global fund scale up rollout of Lenacapavir across 20+ countries |
Medical Dialogues |
India |
|
10 |
17 04 2026 |
NPPA cannot fix prices for Non-scheduled formualtions under DPCO: Bombay HC |
Pharmabiz |
India |
|
11 |
17 04 2026 |
After 66 child deaths, a clean chit, and a ‘vanishing act’, Maiden Pharma is coming back, rebranded |
The News Minute |
India |
|
12 |
17 04 2026 |
Mankind Pharma founder Shri Ramesh Juneja Honoured with Punjab Ratan award |
Medical Dialogues |
India |
|
13 |
17 04 2026 |
Alembic Pharmaceuticals receives FDA approval for Methotrexate Injection for patients with cancer |
Onc nursing News |
India |
|
14 |
16 04 2026 |
India tightens import norms for Glufosinate for six months for effective regulatory oversight |
Pharmabiz |
India |
|
15 |
16 04 2026 |
DCGI to inaugurate 11th edition of ‘Pharmac South’ in Chennai on June 4 |
Pharmabiz |
India |
|
16 |
16 04 2026 |
Gujarat FDCA issues directive to ayurvedic manufacturers for mandatory online registration |
Pharmabiz |
India |
|
17 |
16 04 2026 |
Medical devices industry raises concern over draft notification proposing fee for tests |
Pharmabiz |
India |
|
18 |
16 04 2026 |
GSK completes acquisition of Canada-based, clinical-stage biopharma company, 35Pharma Inc |
Pharmabiz |
India |
|
19 |
16 04 2026 |
Engineering exports overtake pharma as Telangana's top driver |
Hyderabad Mail |
India |
|
20 |
16 04 2026 |
Indian Pharma sites see fewer USFDA official actions in FY 26 even as surprise inspections expand |
Money Control |
India |
